OXFORD ENDOVASCULAR LIMITED
OXFORD

Hellopages » Oxfordshire » Vale of White Horse » OX2 0FB

Company number 09769779
Status Active
Incorporation Date 9 September 2015
Company Type Private Limited Company
Address SEACOURT TOWER, WEST WAY, OXFORD, OXFORDSHIRE, UNITED KINGDOM, OX2 0FB
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration fourteen events have happened. The last three records are Confirmation statement made on 9 September 2016 with updates; Director's details changed for Professor James Byrne on 28 January 2016; Director's details changed for Xie Feng on 23 December 2015. The most likely internet sites of OXFORD ENDOVASCULAR LIMITED are www.oxfordendovascular.co.uk, and www.oxford-endovascular.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and three months. Oxford Endovascular Limited is a Private Limited Company. The company registration number is 09769779. Oxford Endovascular Limited has been working since 09 September 2015. The present status of the company is Active. The registered address of Oxford Endovascular Limited is Seacourt Tower West Way Oxford Oxfordshire United Kingdom Ox2 0fb. . BLAKELAW SECRETARIES LIMITED is a Secretary of the company. BYRNE, James Vincent, Professor is a Director of the company. FENG, Xie is a Director of the company. HOWLETT, Brian is a Director of the company. KARIM, Michael is a Director of the company. MCLEAN, Andrew, Dr is a Director of the company. PORTER, Carolyn Breege, Doctor is a Director of the company. The company operates in "Research and experimental development on biotechnology".


Current Directors

Secretary
BLAKELAW SECRETARIES LIMITED
Appointed Date: 09 September 2015

Director
BYRNE, James Vincent, Professor
Appointed Date: 23 December 2015
75 years old

Director
FENG, Xie
Appointed Date: 23 December 2015
41 years old

Director
HOWLETT, Brian
Appointed Date: 23 December 2015
81 years old

Director
KARIM, Michael
Appointed Date: 09 September 2015
59 years old

Director
MCLEAN, Andrew, Dr
Appointed Date: 23 December 2015
40 years old

Director
PORTER, Carolyn Breege, Doctor
Appointed Date: 23 December 2015
55 years old

Persons With Significant Control

Oxford Sciences Innovation Plc
Notified on: 6 April 2016
Nature of control: Ownership of shares – More than 25% but not more than 50%

OXFORD ENDOVASCULAR LIMITED Events

22 Sep 2016
Confirmation statement made on 9 September 2016 with updates
29 Jan 2016
Director's details changed for Professor James Byrne on 28 January 2016
27 Jan 2016
Director's details changed for Xie Feng on 23 December 2015
20 Jan 2016
Appointment of Dr Andrew Mclean as a director on 23 December 2015
15 Jan 2016
Statement of capital following an allotment of shares on 24 December 2015
  • GBP 2,333.32

...
... and 4 more events
15 Jan 2016
Appointment of Mr Brian Howlett as a director on 23 December 2015
15 Jan 2016
Appointment of Professor James Byrne as a director on 23 December 2015
22 Dec 2015
Sub-division of shares on 10 December 2015
22 Dec 2015
Statement of capital following an allotment of shares on 10 December 2015
  • GBP 804.00

09 Sep 2015
Incorporation
Statement of capital on 2015-09-09
  • GBP 1
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)